Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Please provide your email address to receive an email when new articles are posted on . Researchers used data from the GRIPHON study and open-label extension study. The median selexipag dose was 1,000 ...

The REVEAL scores were superior to the ESC/ERS risk 2022 score and the COMPERA registry 3-strata risk score in predicting PH survival. Risk stratification scoring systems designed for pulmonary ...

Women with pulmonary hypertension have a lower risk of death than men, suggesting sex should be considered as a risk factor, ...

Please provide your email address to receive an email when new articles are posted on . The updated European Society of Cardiology risk assessment tool accurately estimated mortality risk among ...

In patients with pulmonary arterial hypertension (PAH), the use of anticoagulants was not associated with improvement in overall survival, and these results were confirmed by an updated meta-analysis.

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results ...

Dr. Sathish Kumar Krishnan has spent years tackling a silent crisis in healthcare: pulmonary hypertension (PH), a condition that affects thousands but remains underdiagnosed and under-treated. As a ...

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...

Pulmonary thromboendarterectomy is a surgery used to treat chronic thromboembolic pulmonary hypertension. It’s the treatment of choice for this condition. Chronic thromboembolic pulmonary hypertension ...